PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 2024Journal of Clinical OncologyOpen Access

Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBenjamin SolomonGLGeoffrey LiuEFEnriqueta Felip

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Solomon et al. (2024) studied this question.

synapsesocial.com/papers/68e67617b6db6435875fff33https://doi.org/10.1200/jco.24.00581
View Full Paper
Ask AI
Bookmark
Share